CH650152A5 - Composition pharmaceutique contenant de l'almitrine. - Google Patents

Composition pharmaceutique contenant de l'almitrine. Download PDF

Info

Publication number
CH650152A5
CH650152A5 CH5348/81A CH534881A CH650152A5 CH 650152 A5 CH650152 A5 CH 650152A5 CH 5348/81 A CH5348/81 A CH 5348/81A CH 534881 A CH534881 A CH 534881A CH 650152 A5 CH650152 A5 CH 650152A5
Authority
CH
Switzerland
Prior art keywords
almitrine
doses
ventilation
respiratory
blood
Prior art date
Application number
CH5348/81A
Other languages
English (en)
French (fr)
Inventor
Etienne Labeyrie
Jean-Pierre Poirier
Francoise Arnaud
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of CH650152A5 publication Critical patent/CH650152A5/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH5348/81A 1980-08-18 1981-08-18 Composition pharmaceutique contenant de l'almitrine. CH650152A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8018074A FR2488509A1 (fr) 1980-08-18 1980-08-18 Nouvelles compositions pharmaceutiques contenant de l'almitrine

Publications (1)

Publication Number Publication Date
CH650152A5 true CH650152A5 (fr) 1985-07-15

Family

ID=9245242

Family Applications (1)

Application Number Title Priority Date Filing Date
CH5348/81A CH650152A5 (fr) 1980-08-18 1981-08-18 Composition pharmaceutique contenant de l'almitrine.

Country Status (14)

Country Link
US (1) US4364946A (OSRAM)
AU (1) AU550741B2 (OSRAM)
BE (1) BE890011A (OSRAM)
CA (1) CA1181694A (OSRAM)
CH (1) CH650152A5 (OSRAM)
DE (1) DE3132654A1 (OSRAM)
FR (1) FR2488509A1 (OSRAM)
GB (1) GB2082064B (OSRAM)
GR (1) GR75328B (OSRAM)
IE (1) IE52095B1 (OSRAM)
IT (1) IT1171461B (OSRAM)
LU (1) LU83556A1 (OSRAM)
NZ (1) NZ198062A (OSRAM)
ZA (1) ZA815664B (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660558B1 (fr) * 1990-04-05 1994-09-09 Adir Utilisation de l'almitrine pour l'obtention de medicaments destines au traitement du paludisme.
ES2688229T3 (es) * 2009-07-31 2018-10-31 Mts Systems Corporation Montaje de ensayo del tren de accionamiento de una turbina eólica
WO2018134265A1 (en) 2017-01-17 2018-07-26 Forrest Michael David Therapeutic inhibitors of the reverse mode of atp synthase
WO2019012149A1 (en) * 2017-07-13 2019-01-17 Forrest Michael David THERAPEUTIC MODULATORS OF THE INVERSE MODE OF ATP SYNTHASE

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1256513A (OSRAM) * 1968-10-02 1971-12-08

Also Published As

Publication number Publication date
ZA815664B (en) 1982-08-25
GR75328B (OSRAM) 1984-07-13
US4364946A (en) 1982-12-21
IT8149104A1 (it) 1983-02-13
LU83556A1 (fr) 1982-04-14
FR2488509A1 (fr) 1982-02-19
IE52095B1 (en) 1987-06-10
BE890011A (fr) 1982-02-18
FR2488509B1 (OSRAM) 1984-11-23
DE3132654A1 (de) 1982-06-24
CA1181694A (fr) 1985-01-29
GB2082064B (en) 1985-06-26
IT8149104A0 (it) 1981-08-13
AU7427781A (en) 1982-02-25
GB2082064A (en) 1982-03-03
AU550741B2 (en) 1986-04-10
IE811891L (en) 1982-02-18
IT1171461B (it) 1987-06-10
NZ198062A (en) 1983-12-16

Similar Documents

Publication Publication Date Title
Parkes Cardiovascular actions of adrenomedullin in conscious sheep
US6845777B2 (en) Composition to reduce or quit smoking addiction
Ebert et al. Circulatory responses to laryngoscopy: the comparative effects of placebo, fentanyl and esmolol
EP0440704B1 (en) Compositions for treating tobacco withdrawel symptoms
JP5902148B2 (ja) 自閉症治療用ジメチルスルホキシド（ｄｍｓｏ）製剤
CH702775B1 (fr) Pastilles de gélatine douces contenant de la nicotine et procédé de préparation.
US20140271890A1 (en) Controlled-release pharmaceutical composition
US6436946B1 (en) Xanthine-containing compositions for oral administration and uses related thereto
JP2024019691A (ja) 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法
Sériès et al. Effects of protriptyline on diurnal and nocturnal oxygenation in patients with chronic obstructive pulmonary disease
CH650152A5 (fr) Composition pharmaceutique contenant de l'almitrine.
Lehtonen et al. Doxazosin effects on insulin and glucose in hypertensive patients
Murray Nicotine as a psychoactive drug
FR2842422A1 (fr) Compositions destinees au traitement des neuropathies peripheriques, preparation et utilisations
FR2634379A1 (fr) Utilisation en therapeutique des benzo(g)quinoleines pour le traitement de la dependance a la nicotine
US20030165585A1 (en) Xanthine-containing compositions for oral administration and uses related thereto
EP1767200A1 (en) Antiaging agent
FR2922109A1 (fr) Composition pharmaceutique ou dietetique pour inhiber l'absorption intestinale du sucre.
CA2417758C (en) Use of the combination of nicotinic acid or derivatives with riboflavin in the manufacture of a medicament for the treatment of primary headaches
Carlino et al. Pulmonary hemodynamic response to acute combination and monotherapy with sildenafil and brain natriuretic peptide in rats with monocrotaline-induced pulmonary hypertension
KAFER et al. Respiratory and cardiovascular responses to hypoxemia and the effects of anesthesia
US20020168403A1 (en) Compositions and therapy for substance addiction
Taboulet et al. A case of life-threatening lactic acidosis after smoke inhalation—interference between β-adrenergic agents and ethanol?
JP7550054B2 (ja) アルコール飲料摂取による悪酔い又は二日酔いの抑制剤
AU2001276672A1 (en) Use of the combination of nicotinic acid or derivatives with riboflavin in the manufacture of a medicament for the treatment of primary headaches

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased